nifedipine has been researched along with Diabetes Mellitus, Type 1 in 32 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our data show that both lisinopril and nifedipine are effective in delaying the occurrence of macroalbuminuria in normotensive IDDM patients with MA." | 9.08 | Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. ( Carta, Q; Crepaldi, G; Deferrari, G; Mangili, R; Navalesi, R; Nosadini, R; Santeusanio, F; Spalluto, A; Vanasia, A; Villa, GM, 1998) |
| "The aim of the present study was to investigate the renal effects of long-term treatment with the calcium channel blocker nifedipine in normotensive type 1 diabetic patients with microalbuminuria." | 9.07 | Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. ( Banyai, M; Capek, M; Kautzky-Willer, A; Prager, R; Schernthaner, G; Schnack, C, 1994) |
| " In the first 3 months, drug dosage was titrated to achieve a decrease in diastolic blood pressure of at least 5 mm HG: Thirty-three patients had a minimum of 24 months' data, and 25 patients were followed up beyond 36 months (mean, 67 +/- 4 months)." | 6.70 | Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; Raffaele, J; Tsalamandris, C, 2001) |
| "Treatment with enalapril for 48 months may have a beneficial effect on the decline of microalbumin excretion in NIDDM patients." | 6.67 | Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. ( Hara, T; Hotta, N; Kawamura, T; Matsumae, H; Matsuo, S; Nakayama, M; Sakamoto, N; Sano, T; Sasaki, H, 1994) |
| "Twelve patients with type 1 diabetes with albuminuria, mild to moderate hypertension and a serum creatinine level of less than 200 mumol l-1 were included." | 6.67 | Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. ( Berg, KJ; Djøseland, O; Endresen, L; Fauchald, P; Hartmann, A; Holdaas, H; Jervell, J; Lien, MG; Nilsen, L, 1991) |
| "Twenty-five stage 2 diabetic nephropathy patients, 39 stage 3 diabetic nephropathy patients, and 12 nondiabetic subjects performed five submaximal cycloergometric exercises (90% of theoretical heart rate) on nonconsecutive days." | 6.67 | Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. ( Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G, 1990) |
| " A total of 54 type 1 diabetic patients with albuminuria and blood pressure (BP) <150/90 mmHg were randomized to receive 10 mg enalapril once daily, 10 mg nifedipine retard twice daily, or placebo in a multicenter double-blind study of 3 years' duration." | 5.09 | Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT). ( , 2001) |
| "Our data show that both lisinopril and nifedipine are effective in delaying the occurrence of macroalbuminuria in normotensive IDDM patients with MA." | 5.08 | Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. ( Carta, Q; Crepaldi, G; Deferrari, G; Mangili, R; Navalesi, R; Nosadini, R; Santeusanio, F; Spalluto, A; Vanasia, A; Villa, GM, 1998) |
| "The aim of the present study was to investigate the renal effects of long-term treatment with the calcium channel blocker nifedipine in normotensive type 1 diabetic patients with microalbuminuria." | 5.07 | Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. ( Banyai, M; Capek, M; Kautzky-Willer, A; Prager, R; Schernthaner, G; Schnack, C, 1994) |
| "The effects of nifedipine retard and captopril on renal haemodynamic parameters have been examined in a double blind randomised cross-over trial in 10 insulin-dependent diabetic males with hypertension (systolic pressure > 150 mmHg or diastolic pressure > 90 mmHg)." | 5.07 | Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. ( Clarke, BF; Cowan, P; Jenkins, DA; Patrick, AW, 1993) |
| "The intraislet insulin hypothesis proposes that glucagon secretion during hypoglycemia is triggered by a decrease in intraislet insulin secretion." | 3.76 | ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation. ( Bryan, J; Harmon, JS; Oseid, EA; Robertson, RP; Slucca, M, 2010) |
| "Nicardipine, a new calcium antagonist, was given to an insulin-treated diabetic patient with severe hypertension that had resisted ordinary antihypertensive treatment." | 3.67 | Effect of nicardipine in a hypertensive patient with diabetes mellitus. ( Miura, K; Sakata, S, 1984) |
| " In the first 3 months, drug dosage was titrated to achieve a decrease in diastolic blood pressure of at least 5 mm HG: Thirty-three patients had a minimum of 24 months' data, and 25 patients were followed up beyond 36 months (mean, 67 +/- 4 months)." | 2.70 | Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; Raffaele, J; Tsalamandris, C, 2001) |
| " We therefore conclude, that long-term use of nifedipine increases UAER in normotensive microalbuminuric insulin-dependent subjects, in contrast to captopril or placebo." | 2.67 | Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus. ( Bakker, K; Bilo, H; Donker, A; Gans, R; Kluitman, E; Michels, B; Potter van Loon, BJ; van Ballegooie, E, 1993) |
| "Treatment with enalapril for 48 months may have a beneficial effect on the decline of microalbumin excretion in NIDDM patients." | 2.67 | Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. ( Hara, T; Hotta, N; Kawamura, T; Matsumae, H; Matsuo, S; Nakayama, M; Sakamoto, N; Sano, T; Sasaki, H, 1994) |
| "Twelve patients with type 1 diabetes with albuminuria, mild to moderate hypertension and a serum creatinine level of less than 200 mumol l-1 were included." | 2.67 | Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. ( Berg, KJ; Djøseland, O; Endresen, L; Fauchald, P; Hartmann, A; Holdaas, H; Jervell, J; Lien, MG; Nilsen, L, 1991) |
| "Twenty-five stage 2 diabetic nephropathy patients, 39 stage 3 diabetic nephropathy patients, and 12 nondiabetic subjects performed five submaximal cycloergometric exercises (90% of theoretical heart rate) on nonconsecutive days." | 2.67 | Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. ( Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G, 1990) |
| "We examined renal responses to a pharmacological dosage of human atrial natriuretic peptide (hANP) and the potential interference of nifedipine administration with the effects of hANP on kidney function in healthy subjects and normoglycemic patients with type 1 diabetes mellitus." | 2.66 | Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus. ( Hofmann, E; Jungmann, E; Scheuermann, EH; Schöffling, K; Seel, K, 1989) |
| "Nifedipine was used for hypertension in 33% of SPK and was associated with better CV and amplitudes, particularly in the upper limbs, where there was less neuropathy." | 1.30 | Diabetic neuropathy after pancreas transplantation: determinants of recovery. ( Al-Harbi, IS; Allen, RD; Chapman, JR; Clouston, PD; Morris, JG; Nankivell, BJ; O'Connell, PJ, 1997) |
| "Verapamil was more effective than nifedipine in improving natriuresis and ANP release to saline load and in lowering the albumin excretion rate." | 1.28 | Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. ( Abaterusso, C; Brocco, E; Carraro, A; Cipollina, MR; Fioretto, P; Frigato, F; Muollo, B; Riva, F; Trevisan, M; Velussi, M, 1992) |
| "Diabetic nephropathy is the dominant cause of hypertension in insulin-dependent diabetics, and long-term rigid antihypertensive treatment inhibits the progression of nephropathy, probably even when there is renal insufficiency." | 1.28 | The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure. ( Conde, N; Gums, G; Heinke, P; Schulz, B; Strese, J; Zander, E; Zander, G, 1990) |
| "Nifedipine induced an increase in plasma renin activity in the control group, as well as in the diabetics." | 1.28 | Effect of nifedipine on renin-angiotensin-aldosterone system and renal prostaglandins in diabetic patients. ( Andonova, K; Borissova, AM; Koev, D; Tcharaktchiev, D; Zacharieva, S, 1989) |
| "Nisoldipine treatment for seven days is not associated with altered platelet function, but platelet hypersensitivity is observed after treatment for 24 hours in both insulin-dependent diabetics and controls." | 1.27 | Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls. ( Betteridge, DJ; Dandona, P; Hendra, TJ; Jeremy, JY; Oughton, J; Smith, CC; Yudkin, JS, 1988) |
| "Nicardipine was used to control hypertensive episodes." | 1.27 | Blood glucose control by an artificial endocrine pancreas in a patient with phaeochromocytoma. ( Hamaji, M; Kawamori, R; Kawashima, Y; Mashimo, T; Miyata, M; Nakao, K; Shichiri, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (34.38) | 18.7374 |
| 1990's | 16 (50.00) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 1 (3.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slucca, M | 1 |
| Harmon, JS | 1 |
| Oseid, EA | 1 |
| Bryan, J | 1 |
| Robertson, RP | 1 |
| White, KE | 1 |
| Bilous, RW | 1 |
| Marshall, SM | 1 |
| El Nahas, M | 1 |
| Remuzzi, G | 1 |
| Piras, G | 1 |
| De Cosmo, S | 1 |
| Viberti, G | 1 |
| Chan, P | 1 |
| Wong, KL | 1 |
| Liu, IM | 1 |
| Tzeng, TF | 1 |
| Yang, TL | 1 |
| Cheng, JT | 1 |
| Sakata, S | 1 |
| Miura, K | 1 |
| Parving, HH | 1 |
| Rossing, P | 1 |
| Hommel, E | 1 |
| Smidt, UM | 1 |
| Bilo, H | 1 |
| Kluitman, E | 1 |
| van Ballegooie, E | 1 |
| Potter van Loon, BJ | 1 |
| Bakker, K | 1 |
| Michels, B | 1 |
| Gans, R | 1 |
| Donker, A | 1 |
| Pernu, HE | 1 |
| Knuuttila, ML | 1 |
| Huttunen, KR | 1 |
| Tiilikainen, AS | 1 |
| Schnack, C | 1 |
| Capek, M | 1 |
| Banyai, M | 1 |
| Kautzky-Willer, A | 1 |
| Prager, R | 1 |
| Schernthaner, G | 1 |
| Sano, T | 1 |
| Kawamura, T | 1 |
| Matsumae, H | 1 |
| Sasaki, H | 1 |
| Nakayama, M | 1 |
| Hara, T | 1 |
| Matsuo, S | 1 |
| Hotta, N | 1 |
| Sakamoto, N | 1 |
| Gøtzsche, O | 1 |
| Sihm, I | 1 |
| Lund, S | 1 |
| Schmitz, O | 1 |
| Jenkins, DA | 1 |
| Cowan, P | 1 |
| Patrick, AW | 1 |
| Clarke, BF | 1 |
| Gupta, N | 1 |
| Ansari, KU | 1 |
| Allen, RD | 1 |
| Al-Harbi, IS | 1 |
| Morris, JG | 1 |
| Clouston, PD | 1 |
| O'Connell, PJ | 1 |
| Chapman, JR | 1 |
| Nankivell, BJ | 1 |
| Crepaldi, G | 1 |
| Carta, Q | 1 |
| Deferrari, G | 1 |
| Mangili, R | 1 |
| Navalesi, R | 1 |
| Santeusanio, F | 1 |
| Spalluto, A | 1 |
| Vanasia, A | 1 |
| Villa, GM | 1 |
| Nosadini, R | 1 |
| Jerums, G | 1 |
| Allen, TJ | 1 |
| Campbell, DJ | 1 |
| Cooper, ME | 1 |
| Gilbert, RE | 1 |
| Hammond, JJ | 1 |
| Raffaele, J | 1 |
| Tsalamandris, C | 1 |
| Fioretto, P | 1 |
| Frigato, F | 1 |
| Velussi, M | 1 |
| Riva, F | 1 |
| Muollo, B | 1 |
| Carraro, A | 1 |
| Brocco, E | 1 |
| Cipollina, MR | 1 |
| Abaterusso, C | 1 |
| Trevisan, M | 1 |
| Holdaas, H | 1 |
| Hartmann, A | 1 |
| Lien, MG | 1 |
| Nilsen, L | 1 |
| Jervell, J | 1 |
| Fauchald, P | 1 |
| Endresen, L | 1 |
| Djøseland, O | 1 |
| Berg, KJ | 1 |
| Romanelli, G | 3 |
| Giustina, A | 3 |
| Cravarezza, P | 2 |
| Caldonazzo, A | 2 |
| Agabiti-Rosei, E | 2 |
| Giustina, G | 3 |
| Washio, M | 1 |
| Onoyama, K | 1 |
| Makita, Y | 1 |
| Fujishima, M | 1 |
| Fujimi, S | 1 |
| Bossoni, S | 2 |
| Cimino, A | 1 |
| Zander, E | 1 |
| Conde, N | 1 |
| Heinke, P | 1 |
| Zander, G | 1 |
| Strese, J | 1 |
| Gums, G | 1 |
| Schulz, B | 1 |
| Jungmann, E | 1 |
| Seel, K | 1 |
| Hofmann, E | 1 |
| Scheuermann, EH | 1 |
| Schöffling, K | 1 |
| Koev, D | 1 |
| Zacharieva, S | 1 |
| Tcharaktchiev, D | 1 |
| Borissova, AM | 1 |
| Andonova, K | 1 |
| Girelli, A | 1 |
| Muiesan, ML | 1 |
| Muiesan, G | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Núñez Jáuregui, P | 1 |
| Hendra, TJ | 1 |
| Oughton, J | 1 |
| Jeremy, JY | 1 |
| Smith, CC | 1 |
| Betteridge, DJ | 1 |
| Dandona, P | 1 |
| Yudkin, JS | 1 |
| Insua, A | 1 |
| Ribstein, J | 1 |
| Mimran, A | 1 |
| Winocour, PH | 1 |
| Waldek, S | 1 |
| Cohen, H | 1 |
| Anderson, DC | 1 |
| Gordon, C | 1 |
| Madhu, S | 1 |
| Singh Verma, NP | 1 |
| Singh, B | 1 |
| Hamaji, M | 1 |
| Miyata, M | 1 |
| Kawamori, R | 1 |
| Shichiri, M | 1 |
| Mashimo, T | 1 |
| Nakao, K | 1 |
| Kawashima, Y | 1 |
1 review available for nifedipine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
15 trials available for nifedipine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Blood Pressure; Calcium Channe | 2002 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; C | 1995 |
Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus.
Topics: Adult; Albuminuria; Captopril; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Male; | 1993 |
Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Blood Chemical Analysis; Blood Pressure; Diabetes Mellitus, Type 1; Double-Blind | 1994 |
Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
Topics: Acetylglucosaminidase; Albuminuria; beta 2-Microglobulin; Blood Pressure; Body Weight; Cholesterol; | 1994 |
Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Double-Blind Method; Human | 1993 |
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Diab | 1998 |
Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium | 2001 |
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Age | 2001 |
Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Blood Pressure; | 1991 |
Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetes Melli | 1991 |
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Topics: Administration, Oral; Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Capt | 1990 |
Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus.
Topics: Administration, Buccal; Adult; Albuminuria; Atrial Natriuretic Factor; Blood Pressure; Diabetes Mell | 1989 |
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients.
Topics: Albuminuria; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Evaluation; Exerc | 1989 |
Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 1; | 1988 |
16 other studies available for nifedipine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation.
Topics: Animals; Calcium Channels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mell | 2010 |
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Ch | 2003 |
Effect of nicardipine in a hypertensive patient with diabetes mellitus.
Topics: Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Humans; Hypertension; Male; Mid | 1984 |
Drug-induced gingival overgrowth and class II major histocompatibility antigens.
Topics: Adult; Amlodipine; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Felodipine; Female; Gingiv | 1994 |
Abnormal changes in transmitral flow after acute exposure to nitroglycerin and nifedipine in uncomplicated insulin-dependent diabetes mellitus: a Doppler echocardiographic study.
Topics: Adult; Blood Flow Velocity; Case-Control Studies; Diabetes Mellitus, Type 1; Diastole; Echocardiogra | 1993 |
Deterioration of carbohydrate metabolism by nifedipine.
Topics: Adult; Animals; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Humans; Insulin; | 1996 |
Diabetic neuropathy after pancreas transplantation: determinants of recovery.
Topics: Adult; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dia | 1997 |
Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Calcium Cha | 1992 |
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a diabetic hemodialysis patient.
Topics: Adult; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Humans; Hypertension | 1991 |
The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
Topics: Acute Kidney Injury; Antihypertensive Agents; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; | 1990 |
Effect of nifedipine on renin-angiotensin-aldosterone system and renal prostaglandins in diabetic patients.
Topics: Adult; Blood Pressure; Diabetes Mellitus, Type 1; Electrolytes; Female; Humans; Kidney; Male; Middle | 1989 |
[Use of nifedipine in patients with advanced arteriosclerotic cardiopathy].
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Cardiac Output, Low; Coronary Artery Diseas | 1986 |
Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Catecholamines; Collagen; Diabetes Mel | 1988 |
Glycaemic control and exercise tolerance in hypertensive insulin-treated diabetes during nifedipine therapy.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Exercise Test; Female; Humans; Hypertension; Male; | 1987 |
Nifedipine in angina and blood glucose levels in diabetics.
Topics: Angina Pectoris; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Nifedi | 1986 |
Blood glucose control by an artificial endocrine pancreas in a patient with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Blood Glucose; Calcium Channel Blockers; Catecholamines; Diabetes Mellitus, | 1985 |